Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts
Title
Grant Type
Focus Area
Country
Application Due Date
Research in Ulcerative Colitis (UC) 2024
Release Date:
Review Process: Expert Review Panel
Research Inflammation & Immunology Australia, Austria, Belgium, Canada, Czech Republic, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Spain, Switzerland, United Kingdom
Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple Myeloma
Release Date:
Review Process: Pfizer Internal
Research Oncology USA
BCMA-Directed Bispecific Antibody Treatment in Multiple Myeloma
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Oncology Japan
Research on MBL producing Enterobacterales and/or Stenotrophomonas maltophilia
Release Date:
Review Process: Pfizer Internal
Research Hospital Austria, Brazil, China, France, Germany, Greece, India, Italy, Mexico, Saudi Arabia, Spain, Taiwan, Turkey, United Kingdom
Increase Awareness & Understanding of Emerging Hemophilia Treatment Options (Global excluding United States)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease All
Optimal management of patients with prostate cancer receiving androgen deprivation therapy (ADT)
Release Date:
Partner: Sumitomo Pharma
Review Process: Pfizer Internal
Education Oncology USA
Title
Grant Type
Focus Area
Country
Application Due Date
Providing Access to Learning Resources for Nurses in Africa
Release Date:
Review Process:
Increasing Adult Pneumococcal Immunization Rates through AAFP State Chapters
Release Date:
Improving Vaccine Utilization and Preventive Health Maintenance in IBD
Release Date:
Review Process:
Supporting Educational Programs for Radical Reform of Pain Treatment in Japan
Release Date:
Review Process:
Improving Pediatric Immunization Care – Innovative Strategies to Improve Childhood Immunization Rates
Release Date:
Review Process:
Rheumatology Nurse Practitioner and Physician Assistant Fellowship
Release Date:
Review Process:
Cardiac Amyloidosis Fellowship
Release Date:
Review Process:
Improving Pneumococcal Immunization of Adults with Immunocompromising Conditions
Release Date:
Review Process:
Efforts for Early Detection of Atrial Fibrillation and Prevention of Cardio Embolic Stroke
Release Date:
Review Process:
Quality Improvement Activities to Prevent Fatal Pulmonary Thromboembolism
Release Date:
Review Process:
Project CHANGE - Clinical practice oriented cHange solutions towards Active aNd healthy aGEing
Release Date:
Review Process:
QI Initiaitives Focused on Undiagnosed Nonvalvular Atrial Fibrillation (NVAF)
Release Date:
Review Process: